Epidemiological studies point to race as a determining factor in cancer susceptibility. In US
registries recording cancer incidence and survival by race (distinguishing 'black versus …

Non-small cell lung cancer (NSCLC) tumours with certain mutations in the epidermal growth
factor receptor (EGFR) tyrosine kinase have been termed 'oncogene addicted'to reflect their …

Core–shell type lipid–polymer hybrid nanoparticles (CSLPHNPs) have emerged as a
multifunctional drug delivery platform. The delivery system combines mechanical …

The cancer testis antigen, melanoma-associated antigen A9 (MAGE-A9), is expressed in
many kinds of different human cancers and is an important target for immunotherapy …

Melanoma associated antigen-A (MAGE-A) is an oncogene and correlated with tumor
initiation and development. However the roles of MAGE-A9 in non-small cell lung cancer …

The present work was developed the pH dependent-aptamer AS1411 (APT) decorated and
erlotinib (En) loaded chitosan nanoparticles (CSNPs) for promising non-small-cell lung …

RAS (H-ras, K-ras, and N-ras), as the second largest mutated gene driver in various human
cancers, has long been a vital research target for cancer. Its function is to transform the …

A new generation of technologies commonly named omics permits assessment of the
entirety of the components of biological systems and produces an explosion of data and a …

Purpose: The epithelial–mesenchymal transition (EMT) is emerging as a critical factor for the
progression and metastasis of carcinomas, as well as drug resistance. The T-box …

Although lung cancer remains the leading cancer killer in the United States, recently a
number of developments indicate future clinical benefit. These include evidence that …